logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shude Cui

Zhengzhou University
H指数:19
被引数:1,634

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive/human epidermal growth factor receptor 2-advanced breast cancer (FRIEND study)

氟维司坦与依西美坦一线治疗中国绝经后雌激素受体阳性/人表皮生长因子受体2-晚期乳腺癌的临床疗效 (FRIEND研究)

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-05-018
PRE
Wang, Jiayu; Cai, Li; Song, Yanqiu; Sun, Tao; Tong, Zhongsheng; Teng, Yuee; Li, Huiping; Ouyang, Quchang; Chen, Qianjun; Cui, Shude; Yin, Yongmei; Liao, Ning; Sun, Qiang; Feng, Jifeng; Wang, Xiaojia; Xu, Binghe
Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Primary results from PALOMA-4

Palbociclib联合来曲唑与安慰剂联合来曲唑治疗亚洲绝经后雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的比较: 来自PALOMA-4的主要结果

EUROPEAN JOURNAL OF CANCER
IF7.1
2022-11-0144
OA
Xu, Binghe; Hu, Xichun; Li, Wei; Sun, Tao; Shen, Kunwei; Wang, Shusen; Cheng, Ying; Zhang, Qingyuan; Cui, Shude; Tong, Zhongsheng; Geng, Cuizhi; Song, Erwei; Huang, Chiun-Sheng; Sriuranpong, Virote; Ngan, Roger K. C.; Chia, Yee H.; Wang, Xinwei; Zhao, Huadong
Relationship Between Lifestyle Habits and Health-Related Quality of Life of Recently Diagnosed Breast Cancer Patients: A Comparison Between Younger and Older Women in China
FRONTIERS IN PUBLIC HEALTH
IF3.4
2021-12-147
OAAI
Zheng, Chao; Yu, Li-Xiang; Jia, Hong-Ying; Cui, Shu-De; Tian, Fu-Guo; Fan, Zhi-Min; Geng, Cui-Zhi; Cao, Xu-Chen; Yang, Zhen-Lin; Wang, Xiang; Liang, Hong; Wang, Shu; Jiang, Hong-Chuan; Duan, Xue-Ning; Wang, Hai-Bo; Li, Guo-Lou; Wang, Qi-Tang; Zhang, Jian-Guo; Jin, Feng; Tang, Jin-Hai; Li, Liang; Zhu, Shi-Guang; Zuo, Wen-Shu; Wang, Fei; Zhou, Fei; Xiang, Yu-Juan; Guo, Ming-Ming; Wang, Yong-Jiu; Huang, Shu-Ya; Liu, Li-Yuan; Yu, Zhi-Gang
Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer
FRONTIERS IN ONCOLOGY
IF3.3
2021-04-2910
OAAI
Zhu, Jiujun; Jiao, Dechuang; Yan, Min; Chen, Xiuchun; Wang, Chengzheng; Lu, Zhenduo; Li, Lianfang; Sun, Xianfu; Qin, Li; Guo, Xuhui; Zhang, Chongjian; Qiao, Jianghua; Li, Jianbin; Fan, Zhimin; Wang, Haibo; Zhang, Jianguo; Yin, Yongmei; Fu, Peifen; Geng, Cuizhi; Jin, Feng; Jiang, Zefei; Cui, Shude; Liu, Zhenzhen
Assessment of CPS plus EG, Neo-Bioscore and Modified Neo-Bioscore in Breast Cancer Patients Treated With Preoperative Systemic Therapy: A Multicenter Cohort Study
FRONTIERS IN ONCOLOGY
IF3.3
2021-03-164
OAAI
Xu, Ling; Liu, Yinhua; Fan, Zhimin; Jiang, Zefei; Liu, Yunjiang; Ling, Rui; Zhang, Jianguo; Yu, Zhigang; Jin, Feng; Wang, Chuan; Cui, Shude; Wang, Shu; Mao, Dahua; Han, Bing; Wang, Tao; Zhang, Geng; Wang, Ting; Guo, Baoliang; Yu, Lixiang; Xu, Yingying; Fu, Fangmeng; Liu, Zhenzhen; Wang, Siyuan; Luo, Ke; Xiang, Qian; Zhang, Zhuo; Liu, Qianxin; Zhou, Bin; Liu, Zhaorui; Ma, Chao; Tong, Weiwei; Mao, Jie; Duan, Xuening; Cui, Yimin
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple-negative breast cancer (cbcsg010): An open-label, randomised, multicentre, phase 3 trial
CANCER RESEARCH
IF16.6
2020-02-151
PRE
Li, Junjie; Yu, Keda; Pang, Da; Wang, Changqin; Jiang, Jun; Yang, Suisheng; Liu, Yunjiang; Fu, Peifen; Sheng, Yuan; Zhang, Guojun; Cao, Yali; He, Qi; Cui, Shude; Wang, Xijing; Ren, Guosheng; Li, Xinzheng; Yu, Shiyou; Liu, Pengxi; Tang, Jinhai; Wang, Ouchen; Fan, Zhimin; Jiang, Guoqin; Zhang, Jin; Shao, Zhimin
Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case-Control Study in Chinese Women
FRONTIERS IN ENDOCRINOLOGY
IF4.6
2020-01-2118
OAAI
Xiang, Yujuan; Zhou, Wenzhong; Duan, Xuening; Fan, Zhimin; Wang, Shu; Liu, Shuchen; Liu, Liyuan; Wang, Fei; Yu, Lixiang; Zhou, Fei; Huang, Shuya; Li, Liang; Zhang, Qiang; Fu, Qinye; Ma, Zhongbing; Gao, Dezong; Cui, Shude; Geng, Cuizhi; Cao, Xuchen; Yang, Zhenlin; Wang, Xiang; Liang, Hong; Jiang, Hongchuan; Wang, Haibo; Li, Guolou; Wang, Qitang; Zhang, Jianguo; Jin, Feng; Tang, Jinhai; Tian, Fuguo; Ye, Chunmiao; Yu, Zhigang
Association of PTPN1 polymorphisms with breast cancer risk: A case-control study in Chinese females
JOURNAL OF CELLULAR BIOCHEMISTRY
IF2.8
2019-02-255
OAAI
Huang, Shuya; Liu, Liyuan; Xiang, Yujuan; Wang, Fei; Yu, Lixiang; Zhou, Fei; Cui, Shude; Tian, Fuguo; Fan, Zhimin; Geng, Cuizhi; Cao, Xuchen; Yang, Zhenlin; Wang, Xiang; Liang, Hong; Wang, Shu; Jiang, Hongchuan; Duan, Xuening; Wang, Haibo; Li, Guolou; Wang, Qitang; Zhang, Jianguo; Jin, Feng; Tang, Jinhai; Li, Liang; Zhu, Shiguang; Zuo, Wenshu; Ye, Chunmiao; Zhou, Wenzhong; Yin, Gengshen; Ma, Zhongbing; Yu, Zhigang
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study
BREAST CANCER RESEARCH AND TREATMENT
IF3
2017-12-1129
PREAI
Xie, Jie; Cao, Jun; Wang, Jing-fen; Zhang, Bai-hong; Zeng, Xiao-hua; Zheng, Hong; Zhang, Yang; Cai, Li; Wu, Yu-dong; Yao, Qiang; Zhao, Xiao-chun; Mao, Wei-dong; Jiang, Ai-Mei; Chen, Shao-shui; Yang, Shun-e; Wang, Shu-sen; Wang, Jian-hong; Pan, Yue-yin; Ren, Bi-yong; Chen, Yan-ju; Ouyang, Li-zhi; Lei, Kai-jian; Gao, Jing-hua; Huang, Wen-he; Huang, Zhan; Shou, Tao; He, Yan-ling; Cheng, Jing; Sun, Yang; Li, Wei-ming; Cui, Shu-de; Wang, Xin; Rao, Zhi-guo; Ma, Hu; Liu, Wei; Wu, Xue-yong; Shen, Wei-xi; Cao, Fei-lin; Xiao, Ze-min; Wu, Biao; Tian, Shu-yan; Meng, Dong; Shen, Peng; Wang, Bi-yun; Wang, Zhonghua; Zhang, Jian; Wang, Leiping; Hu, Xi-chun

研究方向

暂未获取到该数据
樊
樊志敏
H 指数:21论文数:136被引数:1,396
刘真真 封面图
刘真真
H 指数:43论文数:474被引数:6,674
C
Cuizhi Geng
H 指数:34论文数:239被引数:4,799
M
Min Yan
H 指数:68论文数:759被引数:1.9万
Z
Zhigang Yu
H 指数:40论文数:228被引数:6,375
J
Jinhai Tang
H 指数:60论文数:374被引数:1.1万
X
Xuening Duan
H 指数:17论文数:94被引数:784
J
Jianguo Zhang
H 指数:55论文数:329被引数:1.8万
Z
Zefei Jiang
H 指数:46论文数:376被引数:1.5万
D
Dechuang Jiao
H 指数:13论文数:64被引数:412